Invention Grant
- Patent Title: Indazole-carboxamide compounds as 5-HT4 receptor agonists
- Patent Title (中): 吲唑 - 甲酰胺化合物作为5-HT 4受体激动剂
-
Application No.: US12012579Application Date: 2008-02-04
-
Publication No.: US07674908B2Publication Date: 2010-03-09
- Inventor: Seok-Ki Choi , Adam A. Goldblum , Daniel D. Long
- Applicant: Seok-Ki Choi , Adam A. Goldblum , Daniel D. Long
- Applicant Address: US CA South San Francisco
- Assignee: Theravance, Inc.
- Current Assignee: Theravance, Inc.
- Current Assignee Address: US CA South San Francisco
- Agent Jeffrey A. Hagenah; Roberta P. Saxon
- Main IPC: C07D451/02
- IPC: C07D451/02

Abstract:
The invention provides novel indazole-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
Public/Granted literature
- US20080146807A1 Indazole-carboxamide compounds as 5-HT4 receptor agonists Public/Granted day:2008-06-19
Information query